Journal details
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
TAYLOR & FRANCIS LTD · ISSN 1478-7210 · eISSN 1744-8336
SCIEScopusMEDLINEPubMedPMC
Overview
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. ISSN 1478-7210 · eISSN 1744-8336. published by TAYLOR & FRANCIS LTD. England. Infectious Diseases · Microbiology · Pharmacology & Pharmacy. impact factor 4.6 (2025). JCR Q1. CAS Zone 3. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 51 articles · 2025: 105 articles · 2024: 111 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of EXPERT REVIEW OF ANTI-INFECTIVE THERAPY?
The impact factor recorded for EXPERT REVIEW OF ANTI-INFECTIVE THERAPY is 4.6 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of EXPERT REVIEW OF ANTI-INFECTIVE THERAPY?
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY is listed in CAS Zone 3.
Which databases index EXPERT REVIEW OF ANTI-INFECTIVE THERAPY?
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.